Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ganswindt

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Physics in Medicine and Biology|November 19, 2015
Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patientsS Schmid, G Landry, C Thieke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2012
Toxicity and outcome of pelvic IMRT for node-positive prostate cancerA-C Müller, J Lütjens, M Alber, et al.
Der Radiologe|March 1, 2012
[Image-guided radiation therapy]J Boda-Heggemann, M Guckenberger, U Ganswindt, et al.
Radiation Oncology (London, England)|July 18, 2018
Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessionsD Reitz, G Carl, S Schönecker, et al.
Technology in Cancer Research & Treatment|November 21, 2018
Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 FractionsG Carl, D Reitz, S Schönecker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 20, 2021
Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients?C R Arnold, A K Lindner, G Schachtner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 25, 2024
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)S A Koerber, S Höcht, D Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2024
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)C Zamboglou, D M Aebersold, C Albrecht, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2025
Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)S K B Spohn, D M Aebersold, C Albrecht, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Physics in Medicine and Biology|November 19, 2015
Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patientsS Schmid, G Landry, C Thieke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2012
Toxicity and outcome of pelvic IMRT for node-positive prostate cancerA-C Müller, J Lütjens, M Alber, et al.
Der Radiologe|March 1, 2012
[Image-guided radiation therapy]J Boda-Heggemann, M Guckenberger, U Ganswindt, et al.
Radiation Oncology (London, England)|July 18, 2018
Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessionsD Reitz, G Carl, S Schönecker, et al.
Technology in Cancer Research & Treatment|November 21, 2018
Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 FractionsG Carl, D Reitz, S Schönecker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 20, 2021
Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients?C R Arnold, A K Lindner, G Schachtner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 25, 2024
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)S A Koerber, S Höcht, D Aebersold, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2024
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)C Zamboglou, D M Aebersold, C Albrecht, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2025
Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)S K B Spohn, D M Aebersold, C Albrecht, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Pageof 3